CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Results 41 - 42 of 42 : « Previous 1 2 3

Recs

1
Member Avatar adviceinvest (67.43) Submitted: 11/29/2006 10:33:18 PM : Outperform Start Price: $6.50 CRY Score: -28.93

Cryolife is a bargain at six and change it should go to at least 10 next year as revenue and profits return for this beaten down company. This is a biotech with a low risk business model.

Report this Post Reply | Reply | Permalink

Recs

0
Member Avatar DuckyDuck (78.21) Submitted: 9/19/2006 9:03:28 PM : Outperform Start Price: $6.70 CRY Score: -37.22

I like the products, not sure about their mgmt.

Report this Post Reply | Reply | Permalink
Results 41 - 42 of 42 : « Previous 1 2 3

Featured Broker Partners


Advertisement